Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

The test substance 1,8-naphylenediamine was evaluated for potential skin sensitizing properties in a maximisation test as decribed by Magnusson and Kligman. The test was performed on male guinea pigs. The following test compound concentrations were used in this test:

Intradermal induction: 5 %

Topical induction: 50 %

Challenge: 50% and 25 %

After the challenge with a 50% suspension all animals revealed a positive reaction, and after the challenge with a 25% suspension 80% of the animals revealed a positive reaction. In the control group no reaction was observed.

Therefore a classification as Xi, R43 (GHS: Skin Sens.1B) ist justified.


Migrated from Short description of key information:
In a valid study 1,8-naphthylenediaminewas tested in a guinea pig maximisation test (GPMT) as described by Magnusson and Kligman

Justification for selection of skin sensitisation endpoint:
Key study used

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available
Additional information:

no data

Justification for classification or non-classification

In the skin sensitization test according Magnusson and Kligman, after the challenge with a 50% suspension 100% of the animals revealed a positive reaction, and after the challenge with a 25% suspension 80% of the animals revealed a positive reaction. In the control group no reaction was observed.

Therefore a classification as Xi, R43 (GHS: Skin Sens.1B) ist justified.